Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Haemonetics (HAE) Non Operating Income (2016 - 2025)

Haemonetics (HAE) has 17 years of Non Operating Income data on record, last reported at -$7.4 million in Q4 2025.

  • For Q4 2025, Non Operating Income rose 18.56% year-over-year to -$7.4 million; the TTM value through Dec 2025 reached -$23.9 million, down 52.63%, while the annual FY2025 figure was -$9.7 million, 25.13% up from the prior year.
  • Non Operating Income reached -$7.4 million in Q4 2025 per HAE's latest filing, down from -$7.2 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $7.0 million in Q2 2024 and bottomed at -$9.1 million in Q4 2024.
  • Average Non Operating Income over 5 years is -$4.2 million, with a median of -$4.5 million recorded in 2021.
  • The widest YoY moves for Non Operating Income: up 436.25% in 2024, down 367.52% in 2024.
  • A 5-year view of Non Operating Income shows it stood at -$4.6 million in 2021, then soared by 77.01% to -$1.1 million in 2022, then tumbled by 84.74% to -$1.9 million in 2023, then plummeted by 367.52% to -$9.1 million in 2024, then increased by 18.56% to -$7.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non Operating Income were -$7.4 million in Q4 2025, -$7.2 million in Q3 2025, and -$8.7 million in Q2 2025.